Search Results - "Clark, Richard V."

Refine Results
  1. 1
  2. 2

    Creatine ( methyl-d 3 ) dilution in urine for estimation of total body skeletal muscle mass: accuracy and variability vs. MRI and DXA by Clark, Richard V, Walker, Ann C, Miller, Ram R, O'Connor-Semmes, Robin L, Ravussin, Eric, Cefalu, William T

    Published in Journal of applied physiology (1985) (01-01-2018)
    “…A noninvasive method to estimate muscle mass based on creatine ( methyl-d ) (D -creatine) dilution using fasting morning urine was evaluated for accuracy and…”
    Get full text
    Journal Article
  3. 3

    Prevalence of Symptomatic Androgen Deficiency in Men by Araujo, Andre B., Esche, Gretchen R., Kupelian, Varant, O’Donnell, Amy B., Travison, Thomas G., Williams, Rachel E., Clark, Richard V., McKinlay, John B.

    “…Context: Despite recognition that androgen deficiency in men should be defined according to biochemical and clinical criteria, most prevalence estimates are…”
    Get full text
    Journal Article
  4. 4

    Total body skeletal muscle mass: estimation by creatine (methyl-d3) dilution in humans by Clark, Richard V, Walker, Ann C, O'Connor-Semmes, Robin L, Leonard, Michael S, Miller, Ram R, Stimpson, Stephen A, Turner, Scott M, Ravussin, Eric, Cefalu, William T, Hellerstein, Marc K, Evans, William J

    Published in Journal of applied physiology (1985) (15-06-2014)
    “…Current methods for clinical estimation of total body skeletal muscle mass have significant limitations. We tested the hypothesis that creatine (methyl-d3)…”
    Get full text
    Journal Article
  5. 5

    Association of sex hormones and C-reactive protein levels in men by Kupelian, Varant, Chiu, Gretchen R., Araujo, Andre B., Williams, Rachel E., Clark, Richard V., McKinlay, John B.

    Published in Clinical endocrinology (Oxford) (01-04-2010)
    “…Summary Objectives  The age‐associated decline in sex hormone levels in men is paralleled by an increase in cardiovascular disease and associated risk factors…”
    Get full text
    Journal Article
  6. 6

    Lean mass, muscle strength, and physical function in a diverse population of men: a population-based cross-sectional study by Araujo, Andre B, Chiu, Gretchen R, Kupelian, Varant, Hall, Susan A, Williams, Rachel E, Clark, Richard V, McKinlay, John B

    Published in BMC public health (21-08-2010)
    “…Age-related declines in lean body mass appear to be more rapid in men than in women but our understanding of muscle mass and function among different subgroups…”
    Get full text
    Journal Article
  7. 7

    The Natural History of Symptomatic Androgen Deficiency in Men: Onset, Progression, and Spontaneous Remission by Travison, Thomas G., Shackelton, Rebecca, Araujo, Andre B., Hall, Susan A., Williams, Rachel E., Clark, Richard V., O'Donnell, Amy B., McKinlay, John B.

    “…OBJECTIVES: To describe the onset, progression, and remission of symptomatic androgen deficiency (SAD) using longitudinal data from the Massachusetts Male…”
    Get full text
    Journal Article
  8. 8

    Predictivity of Nonclinical Male Reproductive Findings for Human Effects by Scialli, Anthony R., Clark, Richard V., Chapin, Robert E.

    Published in Birth defects research (15-01-2018)
    “…Background Testing of pharmaceutical products for reproductive toxicity in male laboratory animals is required for registration. Methods We evaluated whether…”
    Get full text
    Journal Article
  9. 9
  10. 10

    GSK2881078, a SARM, produces dose-dependent increases in lean mass in healthy older men and women by Neil, David, Clark, Richard V, Magee, Mindy, Billiard, Julia, Chan, Ann, Xue, Zhengyu, Russell, Alan

    “…GlaxoSmithKline (GSK) 2881078 is a nonsteroidal, selective androgen receptor modulator (SARM) under investigation by GSK for treatment of reduced mobility and…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Safety, pharmacokinetics and pharmacological effects of the selective androgen receptor modulator, GSK2881078, in healthy men and postmenopausal women by Clark, Richard V., Walker, Ann C., Andrews, Susan, Turnbull, Philip, Wald, Jeffrey A., Magee, Mindy H.

    Published in British journal of clinical pharmacology (01-10-2017)
    “…Aim Selective androgen receptor modulators (SARMs) induce anabolic effects on muscle without the adverse effects of androgenic steroids. In this first‐in‐human…”
    Get full text
    Journal Article
  13. 13

    Large divergence in testosterone concentrations between men and women: Frame of reference for elite athletes in sex‐specific competition in sports, a narrative review by Clark, Richard V., Wald, Jeffrey A., Swerdloff, Ronald S., Wang, Christina, Wu, Frederick C. W., Bowers, Larry D., Matsumoto, Alvin M.

    Published in Clinical endocrinology (Oxford) (01-01-2019)
    “…Summary Objective The purpose of this narrative review was to summarize available data on testosterone levels in normal, healthy adult males and females, to…”
    Get full text
    Journal Article
  14. 14

    Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of life by Williams, Rachel E, Levine, Kristen B, Kalilani, Linda, Lewis, Jacqueline, Clark, Richard V

    Published in Maturitas (20-02-2009)
    “…Abstract Objective To use the Menopause-Specific Quality of Life Questionnaire (MENQOL) to assess the impact of menopausal symptoms on health-related quality…”
    Get full text
    Journal Article
  15. 15
  16. 16

    The Effect of 5α-Reductase Inhibition with Dutasteride and Finasteride on Semen Parameters and Serum Hormones in Healthy Men by Amory, John K., Wang, Christina, Swerdloff, Ronald S., Anawalt, Bradley D., Matsumoto, Alvin M., Bremner, William J., Walker, Susan E., Haberer, Lynda J., Clark, Richard V.

    “…Context: Dutasteride and finasteride are 5α-reductase inhibitors (5ARIs) that dramatically reduce serum levels of dihydrotestosterone (DHT). Objective: Because…”
    Get full text
    Journal Article
  17. 17

    Association between low muscle mass, functional limitations and hospitalisation in heart failure: NHANES 1999-2004 by DiBello, Julia R, Miller, Ram, Khandker, Rezaul, Bourgeois, Nancy, Galwey, Nicholas, Clark, Richard V

    Published in Age and ageing (01-11-2015)
    “…Muscle mass decreases with age, and heart failure (HF) patients may experience greater reductions due to pathophysiological processes associated with this…”
    Get full text
    Journal Article
  18. 18

    Correlates of Low Testosterone and Symptomatic Androgen Deficiency in a Population-Based Sample by Hall, Susan A., Esche, Gretchen R., Araujo, Andre B., Travison, Thomas G., Clark, Richard V., Williams, Rachel E., McKinlay, John B.

    “…Context: Risk factors for low testosterone and symptomatic androgen deficiency (AD) may be modifiable. Objective: Our objective was to examine demographic,…”
    Get full text
    Journal Article
  19. 19

    Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor by Clark, Richard V., Hermann, David J., Cunningham, Glenn R., Wilson, Timothy H., Morrill, Betsy B., Hobbs, Stuart

    “…Dihydrotestosterone (DHT) is the primary metabolite of testosterone in the prostate and skin. Testosterone is converted to DHT by 5α-reductase, which exists in…”
    Get full text
    Journal Article
  20. 20

    Healthcare seeking and treatment for menopausal symptoms in the United States by Williams, Rachel E, Kalilani, Linda, DiBenedetti, Dana Britt, Zhou, Xiaolei, Fehnel, Sheri E, Clark, Richard V

    Published in Maturitas (20-12-2007)
    “…Abstract Objectives A population-based study was used to describe healthcare seeking behavior for menopausal symptoms and treatment among women 40–65 years old…”
    Get full text
    Journal Article